Reversible ventricular arrythmia induced by dasatinib

KEY CLINICAL MESSAGE: Ventricular arrhythmias induced by dasatinib are rare events, but physicians in charge of chronic myeloid leukemia patients should be aware of such potential complications and the need for regular ECG controls during treatment with tyrosine kinase inhibitors.

Detalles Bibliográficos
Autores principales: Spechbach, Hervé, Morel, Philippe, Lorenzini, Kuntheavy Ing, Besson, Marie, Gétaz, Laurent, Sunthorn, Henri, Chalandon, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184536/
https://www.ncbi.nlm.nih.gov/pubmed/25356203
http://dx.doi.org/10.1002/ccr3.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184536/
https://www.ncbi.nlm.nih.gov/pubmed/25356203
http://dx.doi.org/10.1002/ccr3.5

Ejemplares similares